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Figure	  1.	  Nuclear	  envelope,	  nuclear	   lamina	  and	  
lamin	  structure.	  The	  nuclear	  envelope	  surrounds	  
the	   nucleus	   and	   is	   made	   up	   of	   the	   nuclear	  
membranes,	  nuclear	  pore	  complexes	  and	  nuclear	  
lamina.	   Lamins,	   which	   are	   type	   V	   intermediate	  
ﬁlament	   proteins,	   are	   major	   structural	   proteins	  
of	  the	  nucleus.	  Concerning	  lamin	  structure,	  there	  
are	   three	   main	   domains:	   α-­‐helical	   rod	   domain,	  
head	  domain	   and	   tail	   domain.	   The	  α-­‐helical	   rod	  
domain	  is	  criCcal	  for	  the	  formaCon	  of	  dimers	  and	  
higher-­‐ordered	   ﬁlaments	   and	   within	   the	   tail	  
domain,	   lamins	   include	   a	   nuclear	   localizaCon	  
signal	  (NLS),	  an	  immunoglobulin-­‐like	  fold	  (Ig	  fold)	  
and	   a	   CAAX	   moCf.	   This	   sequence	   at	   their	  
carboxyl-­‐termini	   acts	   as	   a	   signal	   to	   trigger	   post-­‐
translaConal	  modiﬁcaCons	   such	   as	   farnesylaCon	  
and	   carboxymethylaCon.	   One	   consequence	   of	  
farnesylaCon	   is	   an	   enhanced	   membrane	  
associaCon,	  either	  directly	  or	  via	  protein-­‐protein	  
interacCons.	  Dauer	  WT	  et	  al.	  (2009)	  	  	  	  	  
Figure	   4.	  Molecular	   and	   cellular	   altera9ons	   in	   HGPS.	   The	   single	   base	   subsCtuCon	  mutaCon	   in	   LMNA	   gene	   acCvates	   a	  
crypCc	  splice	  site,	  which	  implies	  the	  deleCon	  of	  150	  nucleoCdes	  and	  50	  amino	  acids.	  The	  internal	  deleCon	  of	  these	  amino	  
acids	  include	  a	  cleavage	  site,	  disrupCng	  the	  last	  cleavage	  step	  of	  prelamin	  A.	  Therefore,	  this	  mutaCon	  ulCmately	  results	  in	  
the	  generaCon	  of	  a	  mutant	  protein	  termed	  progerin,	  which	  is	  permanently	  farnesylated.	  This	  protein	   is	  toxic	  to	  cells	  and	  
displays	   altered	   structural	   and	   biochemical	   properCes,	   leading	   to	   disrupted	   cellular	   phenotypes	   and	   nuclear	   funcCons.	  	  
Drawn	  by	  author,	  modifying	  ﬁgures	  of	  López-­‐OEn	  C	  et	  al.	  (2013)	  and	  Capel	  BC	  et	  al.	  (2009).	  	  
§  To	  analyse	  the	  nuclear	  lamina	  and,	  in	  parCcular,	  lamin	  A.	  The	  objecCve	  of	  this	  general	  part	  focuses	  on	  the	  structure,	  the	  posSranslaConal	  processing,	  
and	  main	  funcCons	  of	  lamin	  A.	  
§  To	  evaluate	  the	  most	  common	  mutaCons,	  symptoms	  and	  molecular	  basis	  of	  the	  chosen	  diseases:	  Emery-­‐Dreifuss	  Muscular	  Dystrophy	  (EDMD),	  Charcot-­‐
Marie-­‐Tooth	  disease	  type	  2B1	  (CMT2B1),	  Familial	  ParCal	  Lipodystrophy	  Dunnigan	  type	  (FPLD)	  and	  Hutchinson-­‐Gilford	  progeria	  syndrome	  (HGPS).	  In	  this	  
review,	  the	  principal	  aim	  is	  to	  demonstrate,	  making	  use	  of	  HGPS,	  the	  extremely	  importance	  of	  the	  correct	  funcConality	  of	  the	  nuclear	  lamina.	  	  
§  Data	  come	  from	  papers	  and	  reviews	  researched	  on	  PubMed	  and	  ScienceDirect	  databases,	  Disease	  AssociaCons	  such	  as	  Progeria	  Research	  FoundaCon,	  
and	  Medical	  websites.	  
§  The	  searching	  was	  focused	  on	  the	  past	  15	  years	  and	  papers	  were	  selected	  according	  to	  their	  data	  of	  publicaCon	  and	  the	  impact	  factor	  of	  the	  journal,	  
although	  some	  of	  them	  were	  chosen	  for	  their	  ﬁgures.	  Taking	  into	  account	  this	  consideraCon,	  a	  total	  of	  95	  references	  were	  read	  but	  only	  73,	  comprising	  
53	  papers	  or	  reviews	  and	  20	  websites,	  were	  included	  in	  the	  ﬁnal	  report.	  All	  these	  data	  were	  classiﬁed	  in	  the	  ﬁle	  folder	  in	  order	  to	  display	  the	  usefulness	  
of	  each	  one.	  	  
§  Key	  words:	  Nuclear	  envelope,	  Nuclear	   lamina,	  Lamin	  A,	  LMNA,	  LMNA	  gene	  mutaCon,	  Laminopathies,	  Hutchinson-­‐Gilford	  progeria	  syndrome,	  HGPS,	  
progerin,	  farnesylaCon,	  aging.	  Another	  key	  words	  used	  in	  the	  report	  are:	  LMNB1,	  LMNB2,	  Emery-­‐Dreifuss	  Muscular	  Dystrophy,	  EDMD,	  Charcot-­‐Marie-­‐
Tooth	  disease	  type	  2B1,	  CMT2B1,	  Familial	  parCal	  lipodystrophy	  Dunnigan	  type,	  FPLD,	  MyoD,	  SREBP1,	  etc.	  
§  In	   addi9on	   to	   their	   structural	   roles,	   providing	  mechanical	   stability,	   lamins	   are	   implicated	   in	   the	   correct	   spa9al	   and	   temporal	   progression	   of	   nuclear	   processes	   such	   as	   chroma9n	  
organiza9on,	  DNA	  replica9on,	  transcrip9on,	  DNA	  repair	  and	  cell-­‐cycle	  progression.	  
§  MutaCons	  in	  human	  LMNA	  gene	  cause	  several	  diseases	  termed	  Laminopathies.	  One	  of	  the	  laminopathic	  diseases	  is	  Hutchinson-­‐Gilford	  progeria	  syndrome	  (HGPS),	  which	  is	  caused	  by	  a	  
spontaneous	  mutaCon	  and	  characterized	  by	  premature	  aging.	  
§  In	  HGPS	  paCents,	  progerin	  aﬀects	  mostly	  Cssues	  of	  mesenchymal	  origin,	  including	  bone,	  skin,	  fat,	  teeth,	  hair	  and	  blood	  vessels.	  	  
§  Noteworthy,	  the	  crypCc	  splice	  site	  acCvated	  in	  HGPS	  to	  produce	  progerin	  is	  also	  used	  at	  low	  frequency	  in	  healthy	  individuals.	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AbbreviaCons	  of	  ﬁgures	  
	  
§  L530P:	  SubsCtuCon	  of	  leucine	  for	  proline	  at	  amino	  acid	  530	  of	  lamin	  A.	  	  
§  R482W:	   SubsCtuCon	   of	   arginine	   for	   tryptophan	   at	   amino	   acid	   482	   of	  
lamin	  A.	  
§  R298C:	  SubsCtuCon	  of	  arginine	  for	  cysteine	  at	  amino	  acid	  298	  of	  lamin	  A.	  
§  C1824T:	   SubsCtuCon	  of	   cytosine	   for	   thymine	  at	  nucleoCde	  1824	  of	   the	  
gene	  LMNA.	  
§  G608G:	  SubsCtuCon	  of	  glycine	  for	  glycine	  at	  amino	  acid	  608.	  
§  NuRD	  proteins:	  Nucleosome	  Remodeling	  Deacetylase	  proteins.	  
§  DDR:	  DNA	  damage	  response.	  
§  H4K16ac:	  AcetylaCon	  of	  histone	  H4	  at	  lysine	  16.	  	  
§  H4K20me3:	  TrimethylaCon	  of	  histone	  H4	  at	  lysine	  20.	  
§  H3K4me3:	  TrimethylaCon	  of	  histone	  H3	  at	  lysine	  4.	  
§  H3K9me3:	  TrimethylaCon	  of	  histone	  H3	  at	  lysine	  9.	  
§  H3K27me3:	  TrimethylaCon	  of	  histone	  H3	  at	  lysine	  27.	  
§  p53:	  Tumor	  supressor	  protein	  p53.	  
§  pRB:	  ReCnoblastoma	  protein.	  
§  ROS:	  ReacCve	  Oxygen	  Species.	  	  
§  SOD:	  Mitochondrial	  Superoxide	  Dismutase.	  
§  ATM:	  Ataxia	  Telangiectasia	  Mutated.	  	  
§  ATR:	  ATM-­‐	  and	  Rad3-­‐related.	  	  
§  SREBP1:	  Sterol	  Regulatory	  Element-­‐Binding	  Protein	  1.	  	  
§  miR-­‐9:	  micro	  RNA	  9,	  which	  is	  brain-­‐speciﬁc.	  	  
MutaCons	  in	  nuclear	  lamins	  or	  other	  proteins	  of	  the	  nuclear	  envelope	  are	  the	  cause	  of	  a	  group	  of	  geneCc	  disorders	  known	  as	  Laminopathies	  which	  aﬀect	  
diﬀerent	  Cssues	  and	  organ	  systems.	  These	  diseases	  brought	  about	  by	  lamins	  alteraCons	  are	  classiﬁed	  in	  two	  types,	  A	  and	  B,	  depending	  on	  the	  gene	  that	  is	  
aﬀected,	  LMNA	  and	  LMNB1	  or	  2,	  respecCvely.	  The	  LMNA	  gene	  encodes	  two	  major	  isoforms,	  lamins	  A	  and	  C,	  and	  two	  minor	  ones,	  AΔ10	  and	  C2.	  However,	  
the	  B-­‐type	  lamins,	  B1,	  B2	  and	  the	  minor	  product	  B3	  are	  encoded	  by	  LMNB1	  and	  LMNB2.	  Taking	  into	  account	  mutaCons,	  lamin	  B	  alteraCons	  tend	  to	  result	  in	  
embryonic	   lethality	   in	   humans.	   Nonetheless,	   diﬀerent	  mutaCons	   in	   LMNA	   can	   be	   considered	   to	   cause	   four	   diﬀerent	   groups	   of	   disorders	   with	   overlap	  
between	  them:	  Diseases	  of	  striated	  muscle,	  peripheral	  neuropathies,	  lipodystrophy	  syndromes	  and	  accelerated	  aging	  disorders.	  The	  chosen	  diseases	  of	  each	  
group	   in	   the	   report	   are:	  Emery-­‐Dreifuss	  Muscular	  Dystrophy	   (EDMD),	  Charcot-­‐Marie-­‐Tooth	  disease	   type	  2B1	   (CMT2B1),	  Familial	   Par9al	   Lipodystrophy	  
Dunnigan	  type	  (FPLD)	  and	  Hutchinson-­‐Gilford	  progeria	  syndrome	  (HGPS)	  whereas	  in	  this	  review	  only	  HGPS	  will	  be	  extensively	  analyse.	  	  	  	  	  	  	  	  	  
Figure	  2.	  The	  most	  common	  muta9ons	  at	   lamin	  A,	  exon	  of	   the	  
LMNA	   gene	   aﬀected	   and	   symptoms	   of	   the	   Laminopathies	   that	  
are	  in	  the	  report.	  HGPS	  is	  not	  showed.	  Dauer	  WT	  et	  al.	  (2009)	  	  	  	  	  
L530P,	  Exon	  9	   R482W,	  Exon	  8	   R298C,	  Exon	  5	  
EDMD	   FPLD	   CMT2B1	  
Figure	  3.	  Nuclear	  morphology	  of	  
HGPS	   cells.	  Double	   labeling	   with	  
lamin	   A/C	   (red)	   and	   lamin	   B	  
(green).	   Adapted	   from	   BuUn-­‐
Israeli	  V	  et	  al.	  (2012)	  	  	  	  	  
The	  Hutchinson-­‐Gilford	  progeria	  syndrome	  is	  a	  premature	  aging	  disorder	  that	  aﬀects	  children.	  Given	  the	  current	  world	  populaCon	  and	  according	  to	  Progeria	  Research	  FoundaCon,	  there	  are	  between	  350	  and	  400	  children	  living	  with	  
Progeria	  worldwide.	  Most	  paCents	  are	  born	  looking	  healthy	  though	  they	  begin	  to	  display	  many	  aging-­‐associated	  symptoms	  at	  18-­‐24	  months	  of	  age.	  One	  of	  these	  manifestaCons	  is	  a	  premature	  arterioscleroCc	  disease	  that	  leads	  to	  hearts	  
aSacks	  and	  strokes	  between	  the	  ages	  of	  13	  and	  20,	  causing	  their	  death	  at	  an	  early	  age.	  But	  in	  contrast	  with	  other	  features,	  age-­‐related	  condiCons	  such	  as	  Alzheimer	  disease,	  demenCa,	  osteoarthriCs	  and	  cancer	  are	  absent.	  
	  
The	  most	  frequent	  mutaCon,	  aﬀecCng	  approximately	  90%	  of	  paCents,	  is	  de	  novo	  autosomal	  dominant	  single	  base	  subsCtuCon	  in	  LMNA	  gene.	  This	  mutaCon	  produces	  a	  truncated	  lamin	  A	  known	  as	  progerin.	  Whereas	  the	  lamin	  proteins	  
in	  healthy	  cells	  move	  dynamically	  between	   the	  nuclear	   lamina	  at	   the	  nuclear	  periphery	  and	   the	  nucleoplasm,	   they	  become	   immobilized	   in	  HGPS	  paCent	  cells,	   leading	   to	   thickening	  of	   the	   lamina.	  Furthermore,	   in	   spite	  of	   increased	  
expression	  of	  progerin	  in	  physiological	  condiCons,	  its	  deposiCon	  in	  the	  arterial	  walls	  might	  render	  HGPS	  cells	  more	  sensiCve	  to	  mechanical	  strain	  and	  contribute	  to	  the	  aberrant	  mechanotransducCon.	  These	  alteraCons	  might	  aﬀect	  the	  
response	  of	  cells	   in	  Cssues	  that	  are	  parCcularly	  exposed	  to	  mechanical	  stress	  such	  as	  the	  vasculature,	  bone	  and	  joints.	  Another	  consequence	  is	  that	  Cssues	  characterized	  by	  a	  high	  degree	  of	  cell	  turnover	  such	  as	  skin	  or	  Cssues	  that	  
undergo	  conCnuous	  growth,	  exhaust	  their	  progenitor	  cells	  resulCng	  in	  an	  early	  depleCon	  of	  stem	  cell	  pools.	  Therefore,	  these	  observaCons	  demonstrate	  that	  the	  nuclear	  envelope	  dysfuncCon	  is	  associated	  with	  altered	  nuclear	  acCvity,	  
impaired	  structural	  dynamics	  and	  aberrant	  cell	  signaling.	  	  
Currently	   there	  are	  no	  eﬀecCve	  treatments	  but	  discovering	  that	  progerin	   is	  permanently	   farnesylated	  suggests	   therapeuCc	  strategies.	  The	  use	  of	   farnesyltransferase	   inhibitors	  
(FTIs)	   such	  as	   lonafarnib,	   is	   a	  potenCal	   approach	  but	  progerin	  was	  also	  modiﬁed	  by	  geranylgeranylaCon	  as	   an	  alternate	  modiﬁcaCon.	   It	   hints	   at	   another	  opCon	  based	  on	   the	  
combinaCon	  of	  FTI	  with	  pravastaCn	  and	  zoledronic	  acid,	  that	  are	  a	  staCn	  and	  an	  aminobisphosphonate,	  respecCvely.	  The	  development	  of	  this	  strategy	  and	  others	  are	  studied	  in	  
clinical	  trials.	  In	  parCcular,	  this	  treatment	  has	  showed	  a	  reducCon	  of	  the	  farnesylated	  form	  of	  progerin	  and	  a	  correcCon	  of	  the	  nuclear	  dysmorphology	  in	  progeroid	  cells.	  	  	  	  	  
The	   expression	   of	   lamin	   A/C	   can	   serve	   as	   a	   risk	   biomarker.	   For	   example,	   in	   colon	   cancer	   there	   is	   a	  
correlaCon	  between	  low	  expression	  levels	  of	  A-­‐type	  lamins	  and	  increased	  recurrence	  in	  advanced	  stage	  
of	  tumour.	  	  
Future	  Approaches	  	  
Figure	   5.	   Clinical	   manifesta9ons	   of	   HGPS	   pa9ents.	   Children	   mainly	   present	   accelerated	   degeneraCve	   changes	   of	   the	   skin,	  
musculoskeletal	  and	  cardiovascular	  systems.	  The	  absence	  of	  primary	  central	  nervous	  system	  has	  been	  connected	  with	  the	  expression	  
of	  a	  brain-­‐speciﬁc	  miRNA,	  which	  might	  down-­‐regulate	  lamin	  A	  and	  progerin.	  In	  these	  paCents,	  mortality	  is	  primarily	  due	  to	  accelerated	  
atherosclerosis	  and	  cardiovascular	  disease	  at	  the	  age	  range	  of	  13-­‐20	  years	  old.	  Lagophthalmos:	  inability	  to	  close	  the	  eyelids	  completely.	  
Micrognathia:	   small	   jaw.	   Circumoral	   cyanosis:	   bluish	   appearance	   around	   the	   mouth.	   Acroosteolysis:	   resorpUon	   of	   bone	   at	   distal	  
phalanges.	  Drawn	  by	  author,	  using	  ﬁgures	  of	  Dauer	  WT	  et	  al.	  (2009),	  Capell	  BC	  et	  al.	  (2009)	  and	  Progeria	  Research	  FoundaUon	  (2010).	  	  	  
Therapeu9c	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Mutant	  splicing	  
